{"transactions":[{"id":4634422,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:20:11.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":32012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":32012,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":32012},"source":{"system":"sec-edgar","filing":"0001878313-26-000100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000100/form4.xml","form_type":"4"}},{"id":4634424,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:18:55.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":38871,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":38871,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":38871},"source":{"system":"sec-edgar","filing":"0001878313-26-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000099/form4.xml","form_type":"4"}},{"id":4634423,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:18:01.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":33536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":33536,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":33536},"source":{"system":"sec-edgar","filing":"0001878313-26-000098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000098/form4.xml","form_type":"4"}},{"id":4634426,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:16:51.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":39634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":39634,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":39634},"source":{"system":"sec-edgar","filing":"0001878313-26-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000097/form4.xml","form_type":"4"}},{"id":4634428,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:15:43.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":32012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":32012,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":32012},"source":{"system":"sec-edgar","filing":"0001878313-26-000096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000096/form4.xml","form_type":"4"}},{"id":4634427,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:14:37.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":32774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":32774,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":32774},"source":{"system":"sec-edgar","filing":"0001878313-26-000095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000095/form4.xml","form_type":"4"}},{"id":4617655,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-15T10:33:04.000Z","date":"2026-09-14","kind":"purchase","planned":false,"acquired":true,"shares":73000,"price":1.37,"value":100010.0,"ownership":{"direct":true},"balance_after":1049121,"source":{"system":"sec-edgar","filing":"0001878313-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1913257/000187831326000087/form4.xml","form_type":"4"}},{"id":4616607,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-14T13:03:34.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":37595,"price":1.3171,"value":49516.3745,"ownership":{"direct":true},"balance_after":773296,"source":{"system":"sec-edgar","filing":"0001878313-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1913253/000187831326000084/form4.xml","form_type":"4"}},{"id":671335,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-01T20:16:26.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":46620,"price":1.35,"value":62937.0,"ownership":{"direct":true},"balance_after":735701,"source":{"system":"sec-edgar","filing":"0001878313-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000082/form4.xml","form_type":"4"}},{"id":671334,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-01T20:16:26.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":78239,"price":1.39,"value":108752.21,"ownership":{"direct":true},"balance_after":689081,"source":{"system":"sec-edgar","filing":"0001878313-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000082/form4.xml","form_type":"4"}},{"id":671333,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-01T20:16:26.000Z","date":"2026-08-26","kind":"purchase","planned":false,"acquired":true,"shares":8931,"price":1.39,"value":12414.09,"ownership":{"direct":true},"balance_after":610842,"source":{"system":"sec-edgar","filing":"0001878313-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000082/form4.xml","form_type":"4"}},{"id":675163,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-26T11:56:42.000Z","date":"2026-08-24","kind":"purchase","planned":false,"acquired":true,"shares":1794,"price":1.33,"value":2386.02,"ownership":{"direct":true},"balance_after":601911,"source":{"system":"sec-edgar","filing":"0001878313-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000079/form4.xml","form_type":"4"}},{"id":677582,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-24T20:09:57.000Z","date":"2026-08-20","kind":"purchase","planned":false,"acquired":true,"shares":11899,"price":1.37,"value":16301.63,"ownership":{"direct":true},"balance_after":600117,"source":{"system":"sec-edgar","filing":"0001878313-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000077/form4.xml","form_type":"4"}},{"id":718388,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:15:26.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":26982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":26982,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":26982},"source":{"system":"sec-edgar","filing":"0001878313-26-000074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000074/form4.xml","form_type":"4"}},{"id":718390,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:14:09.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":26355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":26355,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":26355},"source":{"system":"sec-edgar","filing":"0001878313-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000073/form4.xml","form_type":"4"}},{"id":718389,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:13:00.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":32630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":32630,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":32630},"source":{"system":"sec-edgar","filing":"0001878313-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000072/form4.xml","form_type":"4"}},{"id":718387,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:11:42.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":27610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":27610,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":27610},"source":{"system":"sec-edgar","filing":"0001878313-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000071/form4.xml","form_type":"4"}},{"id":718386,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:10:33.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":32003,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":32003,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":32003},"source":{"system":"sec-edgar","filing":"0001878313-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000070/form4.xml","form_type":"4"}},{"id":718385,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:09:21.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":26355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":26355,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":26355},"source":{"system":"sec-edgar","filing":"0001878313-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000069/form4.xml","form_type":"4"}},{"id":755129,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T13:02:16.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":72700,"price":1.3877,"value":100885.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.3634 to $1.4150, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":976121,"source":{"system":"sec-edgar","filing":"0001878313-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000062/form4.xml","form_type":"4"}},{"id":755128,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T13:01:25.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":75000,"price":1.336,"value":100200.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1519178,"source":{"system":"sec-edgar","filing":"0001878313-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000061/form4.xml","form_type":"4"}},{"id":755127,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-02T13:00:31.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.345,"value":2690.0,"ownership":{"direct":true},"balance_after":46511,"source":{"system":"sec-edgar","filing":"0001878313-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000060/form4.xml","form_type":"4"}},{"id":757259,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2026-06-01T12:54:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 29, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":800000,"derivative":{"exercise_price":1.39,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001878313-26-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000053/form4.xml","form_type":"4"}},{"id":757258,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2026-06-01T12:51:53.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 29, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":1.39,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001878313-26-000051","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000051/form4.xml","form_type":"4"}},{"id":757256,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42819,"kind":"person","name":"Himmelreich Jeffrey C","position":1,"cik":"0002001189","reported_name":"Himmelreich Jeffrey C","relationship":{"officer":true,"officer_title":"Head of Finance"}}],"security":"Stock Options","published_at":"2026-06-01T12:49:26.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 29, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":60000,"derivative":{"exercise_price":1.39,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001878313-26-000049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000049/form4.xml","form_type":"4"}},{"id":808889,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2026-04-14T12:45:39.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 10, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":800000,"derivative":{"exercise_price":1.28,"exercise_date":"2027-04-10","expiration_date":"2036-04-10","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001878313-26-000047","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000047/form4.xml","form_type":"4"}},{"id":808890,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2026-04-14T12:44:12.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 10, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":1.28,"exercise_date":"2027-04-10","expiration_date":"2036-04-10","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001878313-26-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000046/form4.xml","form_type":"4"}},{"id":808887,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42819,"kind":"person","name":"Himmelreich Jeffrey C","position":1,"cik":"0002001189","reported_name":"Himmelreich Jeffrey C","relationship":{"officer":true,"officer_title":"Head of Finance"}}],"security":"Stock Options","published_at":"2026-04-14T12:42:09.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 10, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":30000,"derivative":{"exercise_price":1.28,"exercise_date":"2027-04-10","expiration_date":"2036-04-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001878313-26-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000044/form4.xml","form_type":"4"}},{"id":819910,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:56:47.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":27907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":27907,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":27907},"source":{"system":"sec-edgar","filing":"0001878313-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000039/form4.xml","form_type":"4"}},{"id":819911,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:55:27.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":27258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":27258,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":27258},"source":{"system":"sec-edgar","filing":"0001878313-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000037/form4.xml","form_type":"4"}},{"id":819909,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:53:36.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":33748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":33748,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":33748},"source":{"system":"sec-edgar","filing":"0001878313-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000035/form4.xml","form_type":"4"}},{"id":819908,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:51:53.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":28556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":28556,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":28556},"source":{"system":"sec-edgar","filing":"0001878313-26-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000033/form4.xml","form_type":"4"}},{"id":819907,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:50:21.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":27258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":27258,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":27258},"source":{"system":"sec-edgar","filing":"0001878313-26-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000031/form4.xml","form_type":"4"}},{"id":819906,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:48:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":33099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":33099,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":33099},"source":{"system":"sec-edgar","filing":"0001878313-26-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000029/form4.xml","form_type":"4"}},{"id":941133,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-12T13:44:30.000Z","date":"2024-05-01","kind":"gift","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These securities were beneficially owned by Mr. Smith through the Stan V Smith CUST Gage Quentin Smith IL UNIF TRNS MIN Act account.  On May 1, 2024, the shares were transferred to The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1444178,"source":{"system":"sec-edgar","filing":"0001878313-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000021/form4.xml","form_type":"4"}},{"id":941132,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-12T13:44:30.000Z","date":"2022-09-19","kind":"purchase","planned":false,"acquired":true,"shares":2700,"price":3.6884,"value":9958.68,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1424178,"source":{"system":"sec-edgar","filing":"0001878313-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000021/form4.xml","form_type":"4"}},{"id":951972,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:44:40.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":24060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":24060,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":24060},"source":{"system":"sec-edgar","filing":"0001878313-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000018/form4.xml","form_type":"4"}},{"id":951971,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:42:31.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":29216,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":29216,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":29216},"source":{"system":"sec-edgar","filing":"0001878313-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000016/form4.xml","form_type":"4"}},{"id":951970,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:41:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":25206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":25206,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":25206},"source":{"system":"sec-edgar","filing":"0001878313-26-000014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000014/form4.xml","form_type":"4"}},{"id":951969,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:39:42.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":29789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":29789,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":29789},"source":{"system":"sec-edgar","filing":"0001878313-26-000012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000012/form4.xml","form_type":"4"}},{"id":951968,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:38:10.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":24060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":24060,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":24060},"source":{"system":"sec-edgar","filing":"0001878313-26-000010","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000010/form4.xml","form_type":"4"}},{"id":951967,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:36:41.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":24633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":24633,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":24633},"source":{"system":"sec-edgar","filing":"0001878313-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000008/form4.xml","form_type":"4"}},{"id":959785,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-12-23T13:18:50.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":57189,"price":1.36,"value":77777.04,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the sixth month anniversary of the issuance date and expire 3-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":57189,"derivative":{"exercise_price":1.36,"exercise_date":"2026-06-22","expiration_date":"2028-12-22","underlying":"Common Stock","underlying_shares":57189},"source":{"system":"sec-edgar","filing":"0001878313-25-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000073/form4.xml","form_type":"4"}},{"id":959784,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-23T13:18:50.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":57189,"price":1.224,"value":69999.336,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1421478,"source":{"system":"sec-edgar","filing":"0001878313-25-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000073/form4.xml","form_type":"4"}},{"id":959782,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-12-23T13:16:48.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":40849,"price":1.36,"value":55554.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the six month anniversary of the issuance date and expire 3-years after the initial issuance date."}],"balance_after":40849,"derivative":{"exercise_price":1.36,"exercise_date":"2026-06-22","expiration_date":"2028-12-22","underlying":"Common Stock","underlying_shares":40849},"source":{"system":"sec-edgar","filing":"0001878313-25-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000071/form4.xml","form_type":"4"}},{"id":959781,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-23T13:16:48.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":40849,"price":1.224,"value":49999.176,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025."}],"balance_after":151873,"source":{"system":"sec-edgar","filing":"0001878313-25-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000071/form4.xml","form_type":"4"}},{"id":959780,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-12-23T13:14:35.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":81699,"price":1.36,"value":111110.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the six month anniversary of the issuance date and expire 3-years after the initial issuance date."}],"balance_after":81699,"derivative":{"exercise_price":1.36,"exercise_date":"2026-06-22","expiration_date":"2028-12-22","underlying":"Common Stock","underlying_shares":81699},"source":{"system":"sec-edgar","filing":"0001878313-25-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000069/form4.xml","form_type":"4"}},{"id":959779,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-23T13:14:35.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":81699,"price":1.224,"value":99999.576,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025"}],"balance_after":1248888,"source":{"system":"sec-edgar","filing":"0001878313-25-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000069/form4.xml","form_type":"4"}},{"id":976339,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-09T21:51:27.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":4580,"price":1.2,"value":5496.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are beneficially owned by Mr. Smith through the Blake Sarai Teitei Smith IL Unif Trns Min Act.  They are beneficially owned by Mr. Smith's family member.  The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4580,"source":{"system":"sec-edgar","filing":"0001878313-25-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000063/form4.xml","form_type":"4"}},{"id":976338,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-09T21:51:27.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":4580,"price":1.19,"value":5450.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through the Gage Quentin Smith IL Unif Trns Min Act.  They are beneficially owned by Mr. Smith's family member.  The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4580,"source":{"system":"sec-edgar","filing":"0001878313-25-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000063/form4.xml","form_type":"4"}},{"id":976337,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-09T21:51:27.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":4580,"price":1.1997,"value":5494.626,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by Mr. Smith through the Travis Deo Zai Zai Smith IL Unif Trns Min Act.  They are beneficially owned by Mr. Smith's family member.  The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4580,"source":{"system":"sec-edgar","filing":"0001878313-25-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000063/form4.xml","form_type":"4"}},{"id":980439,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T12:31:28.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":10500,"price":0.9661,"value":10144.05,"ownership":{"direct":true},"balance_after":831421,"source":{"system":"sec-edgar","filing":"0001878313-25-000060","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000060/form4a.xml","form_type":"4/A","original_submission_date":"2025-11-28"}},{"id":980438,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T12:30:22.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.1366,"value":56830.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4 filed on December 1, 2025 had the incorrect total share balance owned by Vlad Vitoc.  This Amended Form 4 is now reflecting the correct share balance owned."}],"balance_after":903421,"source":{"system":"sec-edgar","filing":"0001878313-25-000059","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000059/form4a.xml","form_type":"4/A","original_submission_date":"2025-12-01"}},{"id":980437,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T12:30:22.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":22000,"price":1.0463,"value":23018.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":853421,"source":{"system":"sec-edgar","filing":"0001878313-25-000059","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000059/form4a.xml","form_type":"4/A","original_submission_date":"2025-12-01"}},{"id":985232,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-01T11:20:50.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":22000,"price":1.0463,"value":23018.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":853421,"source":{"system":"sec-edgar","filing":"0001878313-25-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000056/form4.xml","form_type":"4"}},{"id":985231,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-01T11:20:50.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.1366,"value":56830.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":881421,"source":{"system":"sec-edgar","filing":"0001878313-25-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000056/form4.xml","form_type":"4"}},{"id":985229,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-01T11:18:37.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":18145,"price":1.1149,"value":20229.8605,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.1147 to $1.1192, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":437628,"source":{"system":"sec-edgar","filing":"0001878313-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000054/form4.xml","form_type":"4"}},{"id":985228,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-01T11:18:37.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.0808,"value":21616.0,"ownership":{"direct":true},"balance_after":419483,"source":{"system":"sec-edgar","filing":"0001878313-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000054/form4.xml","form_type":"4"}},{"id":985227,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-01T11:14:55.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.0388,"value":15582.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.051, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1364289,"source":{"system":"sec-edgar","filing":"0001878313-25-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000052/form4.xml","form_type":"4"}},{"id":986266,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-28T11:52:10.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9785,"value":9785.0,"ownership":{"direct":true},"balance_after":399483,"source":{"system":"sec-edgar","filing":"0001878313-25-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000050/form4.xml","form_type":"4"}},{"id":986267,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-28T11:48:13.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":10500,"price":0.9661,"value":10144.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9606 to $0.9745, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":831421,"source":{"system":"sec-edgar","filing":"0001878313-25-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000047/form4.xml","form_type":"4"}},{"id":987307,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-26T21:43:40.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.98,"value":14700.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9550 to $1.05, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1349289,"source":{"system":"sec-edgar","filing":"0001878313-25-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000045/form4.xml","form_type":"4"}},{"id":987306,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-26T21:43:40.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.99,"value":9900.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9675 to $0.9899, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1334289,"source":{"system":"sec-edgar","filing":"0001878313-25-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000045/form4.xml","form_type":"4"}},{"id":988833,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-25T21:15:03.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9891,"value":9891.0,"ownership":{"direct":true},"balance_after":820921,"source":{"system":"sec-edgar","filing":"0001878313-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000040/form4.xml","form_type":"4"}},{"id":988832,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-25T21:15:03.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1800,"price":0.92,"value":1656.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9128 to $0.9235, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":810921,"source":{"system":"sec-edgar","filing":"0001878313-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000040/form4.xml","form_type":"4"}},{"id":1023450,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:33:37.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":24844,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":24844,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":24844},"source":{"system":"sec-edgar","filing":"0001878313-25-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000037/form4.xml","form_type":"4"}},{"id":1023449,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:29:04.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":20459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20459,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":20459},"source":{"system":"sec-edgar","filing":"0001878313-25-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000035/form4.xml","form_type":"4"}},{"id":1023448,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:26:40.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":21434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":21434,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":21434},"source":{"system":"sec-edgar","filing":"0001878313-25-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000033/form4.xml","form_type":"4"}},{"id":1023447,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:24:44.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":25331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":25331,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":25331},"source":{"system":"sec-edgar","filing":"0001878313-25-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000031/form4.xml","form_type":"4"}},{"id":1023446,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:23:14.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":20459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20459,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":20459},"source":{"system":"sec-edgar","filing":"0001878313-25-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000029/form4.xml","form_type":"4"}},{"id":1023445,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:21:30.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":20946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20946,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":20946},"source":{"system":"sec-edgar","filing":"0001878313-25-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000027/form4.xml","form_type":"4"}},{"id":1027532,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-10-02T20:51:47.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":19230,"price":1.57,"value":30191.1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on October 1, 2025.  The options are exercisable beginning on the six-month anniversary of the issuance date and expire 3-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":19230,"derivative":{"exercise_price":1.57,"exercise_date":"2026-04-01","expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":19230},"source":{"system":"sec-edgar","filing":"0001878313-25-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000019/form4.xml","form_type":"4"}},{"id":1027531,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-02T20:51:47.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":19230,"price":1.3,"value":24999.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on October 1, 2025"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1324289,"source":{"system":"sec-edgar","filing":"0001878313-25-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000019/form4.xml","form_type":"4"}},{"id":1095578,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:17:45.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":20380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20380,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":20380},"source":{"system":"sec-edgar","filing":"0001127602-25-018658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018658/form4.xml","form_type":"4"}},{"id":1095577,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:16:50.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":20865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20865,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":20865},"source":{"system":"sec-edgar","filing":"0001127602-25-018656","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018656/form4.xml","form_type":"4"}},{"id":1095576,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:16:10.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":25232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":25232,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":25232},"source":{"system":"sec-edgar","filing":"0001127602-25-018655","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018655/form4.xml","form_type":"4"}},{"id":1095575,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:14:56.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":24747,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":24747,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":24747},"source":{"system":"sec-edgar","filing":"0001127602-25-018653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018653/form4.xml","form_type":"4"}},{"id":1095574,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:13:57.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":21350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":21350,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":21350},"source":{"system":"sec-edgar","filing":"0001127602-25-018651","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018651/form4.xml","form_type":"4"}},{"id":1095568,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:13:00.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":20380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20380,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":20380},"source":{"system":"sec-edgar","filing":"0001127602-25-018648","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018648/form4.xml","form_type":"4"}},{"id":1121529,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-06-05T20:42:27.000Z","date":"2025-06-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.71,"value":56999.43,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on June 3, 2025.  The options are exercisable beginning on the six-month anniversary of the issuance date and expire 5-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust dated 1993."}],"balance_after":33333,"derivative":{"exercise_price":1.71,"exercise_date":"2025-12-03","expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001127602-25-016869","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225016869/form4.xml","form_type":"4"}},{"id":1121528,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-05T20:42:27.000Z","date":"2025-06-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.5,"value":49999.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1305059,"source":{"system":"sec-edgar","filing":"0001127602-25-016869","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225016869/form4.xml","form_type":"4"}},{"id":1145655,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2025-05-16T20:15:26.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 14, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":1.76,"expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001127602-25-014670","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225014670/form4.xml","form_type":"4"}},{"id":1145656,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2025-05-16T20:14:36.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 14, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":200000,"derivative":{"exercise_price":1.76,"expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-25-014669","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225014669/form4.xml","form_type":"4"}},{"id":1145654,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42819,"kind":"person","name":"Himmelreich Jeffrey C","position":1,"cik":"0002001189","reported_name":"Himmelreich Jeffrey C","relationship":{"officer":true,"officer_title":"Head of Finance"}}],"security":"Stock Options","published_at":"2025-05-16T20:13:34.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 14, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":40000,"derivative":{"exercise_price":1.76,"expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001127602-25-014667","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225014667/form4.xml","form_type":"4"}},{"id":1152380,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-05-12T20:14:02.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.05,"value":41000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on May 8, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."}],"balance_after":20000,"derivative":{"exercise_price":2.05,"exercise_date":"2026-05-08","expiration_date":"2031-05-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-25-013965","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013965/form4.xml","form_type":"4"}},{"id":1152379,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-12T20:14:02.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.5,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on May 8, 2025."}],"balance_after":588218,"source":{"system":"sec-edgar","filing":"0001127602-25-013965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013965/form4.xml","form_type":"4"}},{"id":1152378,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-05-12T20:12:43.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":66666,"price":2.05,"value":136665.3,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on May 8, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":66666,"derivative":{"exercise_price":2.05,"exercise_date":"2026-05-08","expiration_date":"2031-05-08","underlying":"Common Stock","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001127602-25-013963","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013963/form4.xml","form_type":"4"}},{"id":1152377,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-12T20:12:43.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":66666,"price":1.5,"value":99999.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 8, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1271726,"source":{"system":"sec-edgar","filing":"0001127602-25-013963","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013963/form4.xml","form_type":"4"}},{"id":1175729,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:49:28.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are benefically owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":24800,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001127602-25-011819","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011819/form4.xml","form_type":"4"}},{"id":1175728,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":2288,"kind":"person","name":"CHAOUKI STEVEN M","position":1,"cik":"0001776865","reported_name":"CHAOUKI STEVEN M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:47:44.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":20667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20667,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":20667},"source":{"system":"sec-edgar","filing":"0001127602-25-011817","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011817/form4.xml","form_type":"4"}},{"id":1175727,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:45:58.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":20291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20291,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":20291},"source":{"system":"sec-edgar","filing":"0001127602-25-011815","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011815/form4.xml","form_type":"4"}},{"id":1175726,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:44:14.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":26304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":26304,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":26304},"source":{"system":"sec-edgar","filing":"0001127602-25-011813","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011813/form4.xml","form_type":"4"}},{"id":1175725,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32977,"kind":"person","name":"Luput Cristian","position":1,"cik":"0001913350","reported_name":"Luput Cristian","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:42:32.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":21042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":21042,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":21042},"source":{"system":"sec-edgar","filing":"0001127602-25-011811","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011811/form4.xml","form_type":"4"}},{"id":1175722,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:41:05.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":20291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20291,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":20291},"source":{"system":"sec-edgar","filing":"0001127602-25-011809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011809/form4.xml","form_type":"4"}},{"id":1222984,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-03-05T21:42:20.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.85,"value":61666.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."}],"balance_after":33333,"derivative":{"exercise_price":1.85,"exercise_date":"2026-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001127602-25-008330","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008330/form4.xml","form_type":"4"}},{"id":1222983,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-05T21:42:20.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.5,"value":49999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025."}],"balance_after":568218,"source":{"system":"sec-edgar","filing":"0001127602-25-008330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008330/form4.xml","form_type":"4"}},{"id":1222982,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-03-05T21:40:57.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.85,"value":46250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":25000,"derivative":{"exercise_price":1.85,"exercise_date":"2026-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-25-008327","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008327/form4.xml","form_type":"4"}},{"id":1222981,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-05T21:40:57.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.5,"value":37500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1205060,"source":{"system":"sec-edgar","filing":"0001127602-25-008327","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008327/form4.xml","form_type":"4"}},{"id":1222980,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-03-05T21:39:20.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.87,"value":93500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This Form 4/A is being filed to correct the \"Date Exercisable\" and \"Expiration Date\" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 3 to \"February 24, 2025\"."},{"field":"shares","element":"transactionShares","label":"F4","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on February 24, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the inital issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":50000,"derivative":{"exercise_price":1.87,"exercise_date":"2026-02-24","expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-25-008322","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008322/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}},{"id":1222979,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-05T21:39:20.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.5,"value":75000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1180060,"source":{"system":"sec-edgar","filing":"0001127602-25-008322","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008322/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}}],"next_cursor":"2025-03-05T21:39:20.000000Z,1222979"}